018479203

NIPD GENETICS Ventrilia cardiovascular test

---

May 25, 2021

Trademark Summary

The trademark application NIPD GENETICS Ventrilia cardiovascular test was filed by NIPD GENETICS BIOTECH LIMITED, a corporation established under the laws of the Republic of Cyprus (the "Applicant"). The application was published for oppositions on June 27, 2021, and it was registered by office on October 4, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on April 19, 2022.

---

Goods And Services

• The mark was filed in class 1 with following description of goods:
  
  1. Kits composed of reagents for genetic testing for medical and scientific research purposes
  2. Kits composed of reagents for genetic testing for medical and scientific research purposes in the field of cardiovascular diseases
  3. Kits composed of reagents for cardiovascular genetic testing for medical and scientific research purposes
  4. Nucleic acid-based kits and reagents for testing cardiovascular diseases for medical and scientific research purposes.
• The mark was filed in class 42 with following description of goods:
  
  1. Medical laboratory services for cardiovascular genetic tests
  2. Medical laboratory services for identifying genetic mutations in development of cardiovascular diseases
  3. Design and development of medical diagnostic tests and products
  4. Medical and scientific research in the field of genetic testing
  5. Providing medical and scientific research information in the field of genetic testing
  6. Genetic testing for scientific research and analysis purposes in the field of cardiovascular genetics
  7. Genetic engineering services
  8. Scientific, laboratory, clinical, medical, and technological research and analysis services in the fields of nucleic acid analysis, cardiovascular testing, and genetics
  9. Scientific research for medical purposes in the area of cardiovascular diseases.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical analysis services for the diagnosis and prognosis of cardiovascular diseases
  2. Medical genetic testing services for diagnosis, prevention and treatment of cardiovascular diseases
  3. Medical testing of biological samples for diagnosis of cardiovascular diseases
  4. Genetic testing and genetic counseling in the field of cardiovascular diseases
  5. Medical and health services relating to DNA and genetics testing
  6. RNA or DNA analysis for cardiovascular disease diagnosis and prognosis.